Real-world evidence of Besponsa in Belgium in acute lymphoblastic leukemia patients according to the prevailing reimbursement criteria

Real-world evidence of Besponsa in Belgium in acute lymphoblastic leukemia patients according to the prevailing reimbursement criteria

Laatst bijgewerkt: 2025-01-14 13:09

Welcome to the technical documentation pages for the project "Creutzfeldt-Jakob disease surveillance (CJD)", provided by the service healthdata.be (Sciensano).